- Home
- PMVP vs CHMI Comparison
PMVP vs CHMI Comparison
Compare PMVP & CHMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMVP
- CHMI
- Stock Information
- Founded
- PMVP 2013
- CHMI 2012
- Country
- PMVP United States
- CHMI United States
- Employees
- PMVP N/A
- CHMI N/A
- Industry
- PMVP Medicinal Chemicals and Botanical Products
- CHMI Real Estate Investment Trusts
- Sector
- PMVP Health Care
- CHMI Real Estate
- Exchange
- PMVP Nasdaq
- CHMI Nasdaq
- Market Cap
- PMVP 82.7M
- CHMI 83.3M
- IPO Year
- PMVP 2020
- CHMI 2013
- Fundamental
- Price
- PMVP $1.41
- CHMI $2.37
- Analyst Decision
- PMVP Strong Buy
- CHMI Hold
- Analyst Count
- PMVP 1
- CHMI 2
- Target Price
- PMVP $5.00
- CHMI N/A
- AVG Volume (30 Days)
- PMVP 778.7K
- CHMI 332.0K
- Earning Date
- PMVP 11-07-2025
- CHMI 11-06-2025
- Dividend Yield
- PMVP N/A
- CHMI 16.88%
- EPS Growth
- PMVP N/A
- CHMI N/A
- EPS
- PMVP N/A
- CHMI N/A
- Revenue
- PMVP N/A
- CHMI $25,461,000.00
- Revenue This Year
- PMVP N/A
- CHMI N/A
- Revenue Next Year
- PMVP N/A
- CHMI $41.64
- P/E Ratio
- PMVP N/A
- CHMI N/A
- Revenue Growth
- PMVP N/A
- CHMI 3.21
- 52 Week Low
- PMVP $0.81
- CHMI $2.25
- 52 Week High
- PMVP $1.84
- CHMI $3.68
- Technical
- Relative Strength Index (RSI)
- PMVP 46.76
- CHMI 41.39
- Support Level
- PMVP $1.38
- CHMI $2.35
- Resistance Level
- PMVP $1.67
- CHMI $2.45
- Average True Range (ATR)
- PMVP 0.10
- CHMI 0.08
- MACD
- PMVP -0.01
- CHMI 0.01
- Stochastic Oscillator
- PMVP 29.74
- CHMI 52.72
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
About CHMI Cherry Hill Mortgage Investment Corporation
Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.